These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 11456146

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E, Kurum T.
    Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561
    [Abstract] [Full Text] [Related]

  • 4. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
    Rusconi P, Gómez-Marín O, Rossique-González M, Redha E, Marín JR, Lon-Young M, Wolff GS.
    J Heart Lung Transplant; 2004 Jul 15; 23(7):832-8. PubMed ID: 15261177
    [Abstract] [Full Text] [Related]

  • 5. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler AB, Savarimuthu SM, Fong KM, Yang IA, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P.
    Pharmacogenet Genomics; 2007 Nov 15; 17(11):941-9. PubMed ID: 18075464
    [Abstract] [Full Text] [Related]

  • 6. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
    Askari H, Semizel E, Bostan OM, Cil E.
    Turk J Pediatr; 2009 Nov 15; 51(1):22-7. PubMed ID: 19378887
    [Abstract] [Full Text] [Related]

  • 7. Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol.
    Giardini A, Formigari R, Bronzetti G, Prandstraller D, Donti A, Bonvicini M, Picchio FM.
    Cardiol Young; 2003 Aug 15; 13(4):333-6. PubMed ID: 14694952
    [Abstract] [Full Text] [Related]

  • 8. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
    Bajcetic M, Kokic Nikolic A, Djukic M, Kosutic J, Mitrovic J, Mijalkovic D, Jovanovic I, Simeunovic S, Spasic MB, Samardzic R.
    Clin Ther; 2008 Apr 15; 30(4):702-14. PubMed ID: 18498919
    [Abstract] [Full Text] [Related]

  • 9. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I, Farmakis D, Parissis JT, Dodouras T, Filippatos G, Tsiapras D, Kremastinos DT.
    J Card Fail; 2007 Mar 15; 13(2):108-13. PubMed ID: 17395050
    [Abstract] [Full Text] [Related]

  • 10. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May 15; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

  • 11. An echocardiographic analysis of the long-term effects of carvedilol on left ventricular remodeling, systolic performance, and ventricular filling patterns in dilated cardiomyopathy.
    Rahko PS.
    Echocardiography; 2005 Aug 15; 22(7):547-54. PubMed ID: 16060890
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.
    Patrianakos AP, Parthenakis FI, Mavrakis HE, Diakakis GF, Chlouverakis GI, Vardas PE.
    Am Heart J; 2005 Nov 15; 150(5):985. PubMed ID: 16290981
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
    Rhodes J, Margossian R, Darras BT, Colan SD, Jenkins KJ, Geva T, Powell AJ.
    Pediatr Cardiol; 2008 Mar 15; 29(2):343-51. PubMed ID: 17885779
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A, Sabbadini G, Salvatore L, Sinagra G, Mestroni L, Pinamonti B, Gregori D, Ciani F, Muzzi A, Klugmann S, Camerini F.
    J Am Coll Cardiol; 1999 Jun 15; 33(7):1926-34. PubMed ID: 10362195
    [Abstract] [Full Text] [Related]

  • 15. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014
    [Abstract] [Full Text] [Related]

  • 16. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R, Tarantini G, Boffa GM, Orlando S, Iliceto S.
    Ital Heart J; 2004 Jul 02; 5(7):517-22. PubMed ID: 15487269
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiological effects of carvedilol administration in patients with dilated cardiomyopathy.
    Kanoupakis EM, Manios EG, Mavrakis HE, Kallergis EM, Lyrarakis GM, Koutalas EP, Vardas PE.
    Cardiovasc Drugs Ther; 2008 Jun 02; 22(3):169-76. PubMed ID: 18205033
    [Abstract] [Full Text] [Related]

  • 18. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L.
    Am Heart J; 2003 Feb 02; 145(2):292-9. PubMed ID: 12595847
    [Abstract] [Full Text] [Related]

  • 19. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
    Kurum T, Tatli E, Yuksel M.
    Tex Heart Inst J; 2007 Feb 02; 34(1):52-9. PubMed ID: 17420794
    [Abstract] [Full Text] [Related]

  • 20. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
    Metra M, Nardi M, Giubbini R, Dei Cas L.
    J Am Coll Cardiol; 1994 Dec 02; 24(7):1678-87. PubMed ID: 7963115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.